Alto Neuroscience (ANRO) Return on Assets (2024 - 2026)
Alto Neuroscience (ANRO) posted Return on Assets of 0.1% for Q1 2026, up 27.71% sequentially from 0.14% in Q4 2025, and down 10.0% YoY from 0.11% in Q1 2025.
Alto Neuroscience (ANRO) Return on Assets (2024 - 2026) Analysis & Trends
Alto Neuroscience has reported Return on Assets for 3 years, with the latest figure at 0.1% in Q1 2026.
- Quarterly Return on Assets fell 10.0% year-over-year to 0.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.1% (down 10.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.1% in Q1 2026 per ANRO's latest filing, from 0.14% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q2 2024 and troughed at 0.15% in Q3 2025.
- A 3-year average of 0.05% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 0 bps in 2025, down 15 bps in 2025.
- Over 3 years, Return on Assets stood at 0.0% in 2024, then sank by 4040 bps to 0.14% in 2025, then climbed by 28 bps to 0.1% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.1%, 0.14%, and 0.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Alto Neuroscience | 1.13 Bn | 1.13 Bn | - | -0.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08% |
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | -0.14% |
| Sep 30, 2025 | -0.15% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |